Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Investigating the Feasibility and Efficacy of Locoregional Intra-arterial Administration of Methylprednisolone as a Bridge Therapy to Treat Symptomatic Flares in Inflammatory Bowel Disease

NCT05587673 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05587673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05587673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Investigating the Feasibility and Efficacy of Locoregional Intra-arterial Administration of Methylprednisolone as a Bridge Therapy to Treat Symptomatic Flares in Inflammatory Bowel Disease
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
October 6, 2022
Completion date
October 11, 2024
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, indeterminate colitis, inflammatory bowel diseases, ulcerative colitis